STOCK TITAN
  1. Home
  2. LABP

Landos Biopharma (LABP) Stock Price, News & Analysis

LABP NASDAQ

Company Description

Landos Biopharma (NASDAQ: LABP) is classified in the pharmaceutical preparation manufacturing industry within the Pharmaceutical Preparations sector and carries a market capitalization of $71.7M, ranking #5,542 among all listed U.S. companies by market cap.

This page collects what Stock Titan holds for LABP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$71.7M
Market Cap
3.1M
Shares outstanding

Landos Biopharma (LABP) stock last traded at $22.93. At a market capitalization of $71.7M, LABP is classified as a micro-cap stock with approximately 3.1M shares outstanding.

See what a $1,000 investment in LABP would be worth today

LABP Rankings

Market Cap
$71.7M
#5,542

Latest News

View All
—

NImmune Biopharma Announces Presentations at Digestive Disease Week 2026 Supporting a Differentiated Profile and Superior Efficacy of Oral, Once-Daily NIM-1324 for IBD

—

NImmune Biopharma to Present Novel Mechanistic, Efficacy and Translational Data on LANCL2-Targeting Therapeutics Supporting Significant Pipeline-in-a-Drug Potential at IMMUNOLOGY2026

-100.00%

AbbVie Completes Acquisition of Landos Biopharma

acquisition
+173.31%

AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases

acquisition
+9.73%

Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results

earnings
+0.23%

Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation

conferences

Landos Biopharma has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, conferences, clinical trial. View all LABP news →

SEC Filings

View All

No SEC filings available for LABP.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

LABP Company Profile & Sector Positioning

Landos Biopharma (LABP) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Landos Biopharma (LABP)?

The current stock price of Landos Biopharma (LABP) is $22.93 as of February 7, 2025.

What is the market cap of Landos Biopharma (LABP)?

The market cap of Landos Biopharma (LABP) is approximately 71.7M. Learn more about what market capitalization means .